Which companies manufacture the drug betaseron?

What companies produce Betaseron?

Betaseron is a brand name for the medication interferon beta-1b, which is used to treat multiple sclerosis. The original manufacturing rights for Betaseron are held by Teva Pharmaceutical Industries, Ltd. [1]. Teva acquired the rights to Betaseron as part of its 2015 purchase of Cephalon, Inc., the original developer of the medication. [2]

Are there biosimilars or generic versions?

Yes, several companies have developed biosimilars or generic versions of interferon beta-1b, which are similar but not identical to the original Betaseron. These include generics produced by Mylan N.V. [3] and Accord Health Corporation. It's essential to note that while these biosimilars are similar to Betaseron, they may not be identical, and patients or healthcare providers should consult their doctor before switching or using either.

Who else is involved in the production process?

Additionally, there are other companies involved in the production and distribution of Betaseron, including:

- Sandoz Pharmaceuticals, a global generic pharmaceutical company that was recently acquired by Novartis AG (formerly known as Novartis AG),
- Hospira, Inc. - a global pharmaceutical company
- Biotechnology firms also participate in research and development of interferon beta-1b.

Patent Expiration

The patents for Betaseron initially expired in 2014. However, due to certain exclusivities and other regulatory exclusivities [4], the marketing exclusivity for Betaseron has continued. [5] According to reports, the final patent for the drug expired in 2023.

Sources:

[1] Teva Pharmaceutical Industries, Ltd. | Company Website (teva.com)

[2] "Deal Spotlight: Teva's $6.75B Cephalon Buyout" (Pharmaceutical Executive, 2015)

[3] Mylan N.V. | Company Website (mylan.com)

[4] "Exclusivities" (FDA.gov)

[5] DrugPatentWatch.com | Betaseron Interferon Beta 1b Patent Expiration (DrugPatentWatch.com)